Saudi Arabia's oil-fueled prosperity, growing population and liberal health spending policies are major drivers of market growth and have generated attractive opportunities for multinational pharmaceutical companies, according to a new report from health advisory firm Decision Resources.
An expanding network of medical facilities and the requirement for mandatory health insurance have fueled market expansion. The government is also privatizing the health care industry and creating more public-private partnership opportunities to spur investment in new medical cities, which will provide improved access to health services.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze